» Articles » PMID: 6284974

Genetic Structure and Transforming Sequence of Avian Sarcoma Virus UR2

Overview
Journal J Virol
Date 1982 Mar 1
PMID 6284974
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently shown that a newly isolated avian sarcoma virus, UR2, is defective in replication and contains no sequences homologous to the src gene of Rous sarcoma virus. In this study, we analyzed the genetic structure and transforming sequence of UR2 by oligonucleotide fingerprinting. The sizes of the genomic RNAs of UR2 and its associated helper virus, UR2AV, were determined to be 24S and 35S, respectively, by sucrose gradient sedimentation. The molecular weight of the 24S UR2 genomic RNA was estimated to be 1.1 x 10(6), corresponding to 3,300 nucleotides, by gel electrophoresis under the native and denatured conditions. RNase T1 oligonucleotide mapping indicated that UR2 RNA contains seven unique oligonucleotides in the middle of the genome and shares eight 5'- and six 3'-terminal oligonucleotides with UR2AV RNA. From these data, we estimated that UR2 RNA contains a unique sequence of about 12 kilobases in the middle of the genome, and contains 1.4 and 0.7 kilobases of sequences shared with UR2AV RNA at the 5' and 3' ends, respectively. Partial sequence analysis of the UR2-specific oligonucleotides by RNase A digestion revealed that there are no homologous counterparts to these oligonucleotides in the RNAs of other avian sarcoma and acute leukemia viruses studied to date. UR2-transformed non-virus-producing cells contain a single 24S viral RNA which is most likely the message coding for the transforming protein of UR2. On the basis of the uniqueness of the transforming sequence, we concluded that UR2 is a new member of the defective avian sarcoma viruses.

Citing Articles

Established, emerging and elusive molecular targets in the treatment of lung cancer.

Gallant J, Lovly C J Pathol. 2018; 244(5):565-577.

PMID: 29344953 PMC: 10182407. DOI: 10.1002/path.5038.


EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis.

Shih C, Chang Y, Huang W, Jang T, Kung H, Wang W Oncogene. 2017; 36(47):6542-6554.

PMID: 28759046 PMC: 5702718. DOI: 10.1038/onc.2017.262.


Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.

Selinger C, Li B, Pavlakis N, Links M, Gill A, Lee A Histopathology. 2016; 70(3):402-411.

PMID: 27599111 PMC: 5225047. DOI: 10.1111/his.13076.


Activated RET and ROS: two new driver mutations in lung adenocarcinoma.

Bos M, Gardizi M, Schildhaus H, Buettner R, Wolf J Transl Lung Cancer Res. 2015; 2(2):112-21.

PMID: 25806222 PMC: 4369857. DOI: 10.3978/j.issn.2218-6751.2013.03.08.


Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros.

Zong C, Poon B, Chen J, Wang L J Virol. 1993; 67(11):6453-62.

PMID: 8411348 PMC: 238081. DOI: 10.1128/JVI.67.11.6453-6462.1993.


References
1.
Loening U . Molecular weights of ribosomal RNA in relation to evolution. J Mol Biol. 1968; 38(3):355-65. DOI: 10.1016/0022-2836(68)90391-4. View

2.
Hanafusa H . Rapid transformation of cells by Rous sarcoma virus. Proc Natl Acad Sci U S A. 1969; 63(2):318-25. PMC: 223567. DOI: 10.1073/pnas.63.2.318. View

3.
Hanafusa T, Miyamoto T, Hanafusa H . A type of chick embryo cell that fails to support formation of infectious RSV. Virology. 1970; 40(1):55-64. DOI: 10.1016/0042-6822(70)90378-8. View

4.
Duesberg P, Vogt P . RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus. Virology. 1973; 54(1):207-19. DOI: 10.1016/0042-6822(73)90130-x. View

5.
Wang L, Duesberg P . Properties and location of poly(A) in Rous sarcoma virus RNA. J Virol. 1974; 14(6):1515-29. PMC: 355682. DOI: 10.1128/JVI.14.6.1515-1529.1974. View